European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
J. Head. Pain; 20 (6), 2019
BACKGROUND AND AIM:
Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...
Trastornos Migrañosos, Trastornos Migrañosos/diagnóstico, Trastornos Migrañosos/tratamiento farmacológico, Trastornos Migrañosos/terapia, Trastornos Migrañosos/prevención & control, Receptores de Péptido Relacionado con el Gen de Calcitonina/uso terapéutico, Péptido Relacionado con Gen de Calcitonina/uso terapéutico, Cefalea, Cefalea/tratamiento farmacológico, Cefalea/diagnóstico, Cefalea/terapia, Cefalea/prevención & control